Novo Nordisk A/S ADR buy The Goldman Sachs Group, Inc.
Start price
22.01.26
/
50%
€53.00
Target price
22.01.27
-
Performance (%)
0.00%
Price
22.01.26
€53.00
Summary
This prediction is currently active. The_Goldman_Sachs_Gr's BUY prediction for Novo Nordisk A/S ADR is currently unchanged. This prediction currently runs until 22.01.27. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Novo Nordisk A/S ADR | 0.00% |
| iShares Core DAX® | -1.673% |
| iShares Nasdaq 100 | -1.346% |
| iShares Nikkei 225® | -1.529% |
| iShares S&P 500 | -1.702% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE:NVO) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Ratings data for NVO provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€42.70
28.11.25
28.11.25
€46.61
28.11.26
28.11.26
24.12%
22.01.26
22.01.26
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€123.00
30.05.24
30.05.24
€144.02
30.05.25
30.05.25
-49.11%
31.05.25
31.05.25